Drug Target Review – Issue 1 2021
In this issue, find articles discussing how high-throughput experimentation can enhance automated molecular discovery, why bNAbs present a promising COVID-19 treatment and how a novel rhinovirus vaccine was developed. Also included are features on immuno-oncology, cell line development and assays.
Included in this issue:
- VACCINE DEVELOPMENT
The development of biomaterial-based vaccine platforms against viruses
Dr Sushma Kumari, Dr Sonal Asthana and Dr Kaushik Chatterjee, Indian Institute of Science
- CELL LINE DEVELOPMENT
Which CHO cell is the right CHO cell?
Dr Louis Boon, Polpharma Biologics Utrecht
Fighting HIV: could antibodies be the answer?
Victoria Rees, Drug Target Review
- LAB AUTOMATION
Expanding accessible chemical space through automated high-throughput experimentation
Dr Sam Liver, The Rosalind Franklin Institute
COVID-19 drug targets and cell-based assays
Sheraz Gul, Fraunhofer Institute and Alp Tegin Sahin, Kadir Has University
Synthesising very long-chain fatty acids to treat retinal conditions
Dr Paul Bernstein, University of Utah
The rest of this content is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!